Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Denis

Showing results (231-240 of 248) with videos related to

Pageof 25
Sort By:
Revue Medicale De Liege|December 15, 1988
[Biological and clinical effects of a new diphosphonate (chloro-4-phenyl) thiomethylene-diphosphonate in Paget's disease of bone]M P Lecart, A M Jeugmans-Huynen, A Albert, et al.
Prostaglandins|December 1, 1982
Synthesis and biological activities of leukotriene F4 and leukotriene F4 sulfoneD Denis, S Charleson, A Rackham, et al.
Advances in Prostaglandin, Thromboxane, and Leukotriene Research|January 1, 1987
L-648,051: an aerosol active leukotriene D4 receptor antagonistT R Jones, Y Guindon, E Champion, et al.
Bulletin De La Societe De Pathologie Exotique Et De Ses Filiales|March 1, 1981
[9 new Salmonella serotypes isolated in Africa and the Antilles]S Le Minor, M Doutre, R Sansonnens, et al.
Canadian Journal of Physiology and Pharmacology|June 1, 1992
Pharmacology of MK-0591 (3-[1-(4-chlorobenzyl)-3-(t-butylthio)-5-(quinolin-2-yl-methoxy)- indol-2-yl]-2,2-dimethyl propanoic acid), a potent, orally active leukotriene biosynthesis inhibitorC Brideau, C Chan, S Charleson, et al.
Journal Francais D'Ophtalmologie|April 12, 2008
[Primary exotropia: importance of cerebral MRI]C Baeteman, D Denis, C Loudot, et al.
Canadian Journal of Physiology and Pharmacology|August 1, 1986
L-649,923, sodium (beta S*, gamma R*)-4-(3-(4-acetyl-3-hydroxy-2-propylphenoxy)-propylthio)- gamma-hydroxy-beta-methylbenzenebutanoate, a selective, orally active leukotriene receptor antagonistT R Jones, R Young, E Champion, et al.
Journal of Medicinal Chemistry|April 3, 1992
Development of 2,3-dihydro-6-(3-phenoxypropyl)-2-(2-phenylethyl)-5-benzofuranol (L-670,630) as a potent and orally active inhibitor of 5-lipoxygenaseC K Lau, P C Bélanger, C Dufresne, et al.
Journal of Medicinal Chemistry|September 1, 1986
Design and synthesis of sodium (beta R*, gamma S*)-4-[[3-(4-acetyl-3-hydroxy-2-propylphenoxy)propyl] thio]-gamma-hydroxy-beta-methylbenzenebutanoate: a novel, selective, and orally active receptor antagonist of leukotriene D4R N Young, P Bélanger, E Champion, et al.
Advances in Prostaglandin, Thromboxane, and Leukotriene Research|January 1, 1986
L-649,923, sodium (beta S*, gamma R*-4-(3-(4-acetyl-3-hydroxy-2-propylphenoxy)propylthio)-gamma-hydroxy -beta-methylbenzenebutanoate. A selective, orally active leukotriene D4 receptor antagonistR N Young, Y Guindon, T R Jones, et al.
Pageof 25

Showing results (231-240 of 248) with videos related to

Sort By:
Pageof 25
Revue Medicale De Liege|December 15, 1988
[Biological and clinical effects of a new diphosphonate (chloro-4-phenyl) thiomethylene-diphosphonate in Paget's disease of bone]M P Lecart, A M Jeugmans-Huynen, A Albert, et al.
Prostaglandins|December 1, 1982
Synthesis and biological activities of leukotriene F4 and leukotriene F4 sulfoneD Denis, S Charleson, A Rackham, et al.
Advances in Prostaglandin, Thromboxane, and Leukotriene Research|January 1, 1987
L-648,051: an aerosol active leukotriene D4 receptor antagonistT R Jones, Y Guindon, E Champion, et al.
Bulletin De La Societe De Pathologie Exotique Et De Ses Filiales|March 1, 1981
[9 new Salmonella serotypes isolated in Africa and the Antilles]S Le Minor, M Doutre, R Sansonnens, et al.
Canadian Journal of Physiology and Pharmacology|June 1, 1992
Pharmacology of MK-0591 (3-[1-(4-chlorobenzyl)-3-(t-butylthio)-5-(quinolin-2-yl-methoxy)- indol-2-yl]-2,2-dimethyl propanoic acid), a potent, orally active leukotriene biosynthesis inhibitorC Brideau, C Chan, S Charleson, et al.
Journal Francais D'Ophtalmologie|April 12, 2008
[Primary exotropia: importance of cerebral MRI]C Baeteman, D Denis, C Loudot, et al.
Canadian Journal of Physiology and Pharmacology|August 1, 1986
L-649,923, sodium (beta S*, gamma R*)-4-(3-(4-acetyl-3-hydroxy-2-propylphenoxy)-propylthio)- gamma-hydroxy-beta-methylbenzenebutanoate, a selective, orally active leukotriene receptor antagonistT R Jones, R Young, E Champion, et al.
Journal of Medicinal Chemistry|April 3, 1992
Development of 2,3-dihydro-6-(3-phenoxypropyl)-2-(2-phenylethyl)-5-benzofuranol (L-670,630) as a potent and orally active inhibitor of 5-lipoxygenaseC K Lau, P C Bélanger, C Dufresne, et al.
Journal of Medicinal Chemistry|September 1, 1986
Design and synthesis of sodium (beta R*, gamma S*)-4-[[3-(4-acetyl-3-hydroxy-2-propylphenoxy)propyl] thio]-gamma-hydroxy-beta-methylbenzenebutanoate: a novel, selective, and orally active receptor antagonist of leukotriene D4R N Young, P Bélanger, E Champion, et al.
Advances in Prostaglandin, Thromboxane, and Leukotriene Research|January 1, 1986
L-649,923, sodium (beta S*, gamma R*-4-(3-(4-acetyl-3-hydroxy-2-propylphenoxy)propylthio)-gamma-hydroxy -beta-methylbenzenebutanoate. A selective, orally active leukotriene D4 receptor antagonistR N Young, Y Guindon, T R Jones, et al.
Pageof 25